Point72 Europe (London) LLP Glaukos Corp Transaction History
Point72 Europe (London) LLP
- $1.06 Billion
- Q1 2024
A detailed history of Point72 Europe (London) LLP transactions in Glaukos Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 38,500 shares of GKOS stock, worth $4.69 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
38,500Holding current value
$4.69 Million% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
274Shares Held
43.6MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$962 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$646 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$260 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$222 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$196 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.8B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...